Clinical Trials in Atlanta

Showing 4301-4320 of 12,850 trials

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

NCT03675126

The purpose of this extension study is to evaluate the safety, tolerability, and pharmacokinetics of repeat administrations of SRP-5051 (vesleteplirsen) in participants with Duchenne muscular dystrophy (DMD) who participated in studies of SRP-5051.

Muscular Dystrophy, Duchenne

Sarepta Therapeutics, Inc.15 participantsStarted Dec 2018

Hartford, Connecticut, United States • Gulf Breeze, Florida, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

NCT04576988

The objectives of this study are to evaluate the efficacy and safety of sotatercept (MK-7962) treatment (plus background pulmonary arterial hypertension (PAH) therapy) versus placebo (plus background PAH therapy) at 24 weeks in adults with PAH. The primary hypothesis of the study is that the participants receiving sotatercept will have improved 6-minute walk distance (6MWD) at 24 weeks compared to participants receiving placebo.

Pulmonary Arterial Hypertension

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA324 participantsStarted Jan 2021

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +117 more locations

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Find Trials by Condition in Atlanta

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

2021 PMT iAge® Intervention Trial by Edifice Health

A Safety and Efficacy Study in Patients With Gastric Cancer

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

International Weight Control Registry

The PREDICT Registry:

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Clinical Evaluation of the i-STAT TBI Test

Breast Cancer Index (BCI) Registry

Randomized Controlled Trial for Vestibular Treatment in Concussion

Pilot Trial of the RUBI Program for Autistic Adults